AbbVie Taps Harvard University for Viral Infection Research Partnership

[cafead]

via AbbVie and Harvard University entered into a $30 million collaborative research alliance to develop therapies against emergent viral infections, with a focus on those caused by coronaviruses and by viruses that lead to hemorrhagic fever.

article source